Numbers Needed to Treat Derived from Meta-Analyses: Pitfalls and Cautions

Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition

Volumn , Issue , 2008, Pages 386-399

  Ebrahim, Shah ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Clinical setting; Meta analyses; Risk reductions; Systematic reviews; Treatment

Indexed keywords

EID: 84948762703     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470693926.ch20     Document Type: Chapter

References (40)

1. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
2. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.
3. Rembold CM. Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy. J Fam Practice 1996;42:577-86.
4. Review: statins prevent stroke, especially in patients with coronary heart disease. Evidence-Based Med 1998;3:10.
5. Crouse JR III, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997;157:1305-10.
6. The Cochrane Database of Systematic Reviews. Available in The Cochrane Library (database on disk and CDROM). The Cochrane Collaboration Issue 2. Oxford: Update Software, 1999.
7. Barnett HJ, Taylor DW, Eliasziw M, et al. for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in symptomatic patients with moderate or severe carotid stenosis. N Engl J Med 1998;339:1415-25.
8. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.
9. Shepherd J, Cobbe S, Ford E, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-7.
10. 4S Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
11. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;14:1001-9.
12. The Long-Term Intervention with Pravastatin in Ischemic Heart Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
13. Anonymous. Statins. Bandolier 1998;47:2-4.
14. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-12.
15. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy - I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
17. Ebrahim S, Davey Smith G. Health promotion in older people for the prevention of coronary heart disease and stroke. London: Health Education Authority, 1996.
18. Ebrahim S, Davey Smith G. The number needed to treat: does it help clinical decision making? J Human Hypertens 1999;13:721-4.
19. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981;283:179-86.
20. Charlton J, Murphy M, Khaw K-T, Ebrahim S, Davey Smith G. Cardiovascular diseases. In: Murphy M, Charlton J, eds. Health of adult Britain 1841-1994, vol 2. London: HMSO, 1997:60-81.
21. Mulrow C, Lau J, Cornell J, Brand B. Antihypertensive drug therapy in the elderly. The Cochrane Library Issue 2. Oxford: Update Software, 1998.
22. Medical Research Council Working Group. MRC Trial of mild hypertension: principal findings. BMJ 1985;291:97-104.
23. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race-sex and age. JAMA 1979;242:2572-7.
24. Fleiss JL. The statistical basis of meta-analysis. Stat Meth Med Res 1993;2:121-45.
25. Egger M, Davey Smith G, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1533-7.
26. D'Amico R, Deeks JJ, Altman DG. Poor reporting of length of follow up in clinical trials and systematic reviews. eBMJ 25 June 1999 http://www.bmj.com/cgi/eletters/318/7197/1548.
27. Morris S, McGuire A, Caro J, Pettitt D. Strategies for the management of hypercholesterolaemia: a systematic review of the cost-effectiveness literature. J Health Serv Res Policy 1997;2:231-50.
28. Jackson RT, Sackett DL. Guidelines for managing raised blood pressure. BMJ 1996;313:64-5.
29. Davey Smith G, Egger M, Phillips AN. Meta-analysis: Beyond the grand mean? BMJ 1997;315:1610-14.
30. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet 1995;345:1616-19.
31. Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ 1996;313:735-8.
32. Ioannidis JP, Cappelleri JC, Lau J, et al. Early or deferred zidovudine therapy in HIVinfected patients without AIDS defining illness. Ann Intern Med 1995;122:856-66.
33. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta-blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-7.
34. McColl A, Smith H, White P, Field J. General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey. BMJ 1998;316:361-5.
35. Hux JE, Naylor CD. Communicating the benefits of chronic preventative therapy: does the format of efficacy data determine patients' acceptance of treatment? Med Decis Making 1995;15:152-7.
36. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ 1995;311:1056-60.
37. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994;309:761-4.
38. Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract 1996;46:661-3.
39. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992;117:916-21.
40. Smeeth L, Haines A, Ebrahim S. Numbers needed to treat derived from meta-analyses -sometimes informative, usually misleading. BMJ 1999;318:1548-51.